BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 120491
Published online Aug 27, 2026. doi: 10.4240/wjgs.120491
Table 1 Comparison of general data between two groups, mean ± SD
Item
Control group (n = 49)
Intervention group (n = 49)
Statistic
P value
Age (years)56.8 ± 12.455.3 ± 13.1t = 0.5800.563
Gender, male, n (%)31 (63.3)29 (59.2)χ2 = 0.1730.677
BMI (kg/m2)23.5 ± 3.224.1 ± 3.5t = 0.8790.382
APACHE II score18.6 ± 4.817.9 ± 5.1t = 0.6980.487
SOFA score 7.2 ± 2.36.9 ± 2.1t = 0.6700.504
Perforation size (cm)1.8 ± 0.71.9 ± 0.8t = 0.6540.514
Table 2 Comparison of inflammatory markers between two groups, mean ± SD
Item
Control group (n = 49)
Intervention group (n = 49)
t value
P value
PCT on admission (ng/mL)12.8 ± 5.613.2 ± 6.10.3360.738
PCT on POD 3 (ng/mL)6.4 ± 3.24.8 ± 2.52.7460.007
PCT on POD 5 (ng/mL)3.1 ± 1.81.9 ± 1.23.858< 0.001
CRP on POD 3 (mg/L)124.8 ± 36.298.6 ± 28.53.964< 0.001
CRP on POD 5 (mg/L)68.4 ± 22.648.2 ± 18.34.832< 0.001
IL-6 on POD 3 (pg/mL)168.5 ± 52.3128.6 ± 42.84.112< 0.001
IL-6 on POD 5 (pg/mL)86.2 ± 28.462.5 ± 21.64.611< 0.001
Table 3 Comparison of hemodynamic parameters between two groups, mean ± SD
Item
Control group (n = 49)
Intervention group (n = 49)
t value
P value
MAP at 12 hours (mmHg)74.8 ± 9.278.6 ± 7.42.2430.027
MAP at 24 hours (mmHg)76.2 ± 8.480.8 ± 6.82.9540.004
MAP at 48 hours (mmHg)78.5 ± 7.682.4 ± 5.92.8080.006
HR at 24 hours (bpm)92.4 ± 12.686.2 ± 10.42.6360.010
HR at 48 hours (bpm)88.2 ± 10.882.6 ± 8.62.8120.006
Table 4 Comparison of sedation and pain assessment between two groups, mean ± SD
Item
Control group (n = 49)
Intervention group (n = 49)
Statistic
P value
Time to target sedation (hours)3.8 ± 1.42.6 ± 1.1t = 4.692< 0.001
CPOT at 6 hours2.4 ± 0.81.8 ± 0.6t = 4.167< 0.001
CPOT at 24 hours1.9 ± 0.71.4 ± 0.5t = 4.037< 0.001
Total opioid (MEQ mg)168.4 ± 42.6124.8 ± 35.2t = 5.486< 0.001
Table 5 Comparison of organ function indicators between two groups, mean ± SD
Item
Control group (n = 49)
Intervention group (n = 49)
t value
P value
PaO2/FiO2 on admission (mmHg)186.4 ± 42.8182.6 ± 45.20.4240.672
PaO2/FiO2 on POD 3 (mmHg)218.6 ± 48.5256.4 ± 52.83.676< 0.001
PaO2/FiO2 on POD 5 (mmHg)268.4 ± 54.2312.6 ± 48.64.215< 0.001
Creatinine on POD 3 (μmol/L)128.6 ± 32.4108.2 ± 28.63.2810.001
Creatinine on POD 5 (μmol/L)102.4 ± 26.886.5 ± 22.43.1630.002
SOFA on POD 35.4 ± 1.84.2 ± 1.53.561< 0.001
SOFA on POD 53.8 ± 1.42.6 ± 1.24.522< 0.001
Table 6 Comparison of lactate metabolism between two groups, mean ± SD
Item
Control group (n = 49)
Intervention group (n = 49)
t value
P value
Lactate on admission (mmol/L)4.8 ± 1.64.6 ± 1.50.6340.528
Lactate at 12 hours (mmol/L)3.6 ± 1.22.8 ± 0.93.712< 0.001
Lactate at 24 hours (mmol/L)2.9 ± 1.02.1 ± 0.74.542< 0.001
Lactate at 48 hours (mmol/L)2.2 ± 0.81.6 ± 0.54.412< 0.001
24h lactate clearance rate (%)38.6 ± 14.852.8 ± 12.45.102< 0.001
Time to lactate normalization (hours)46.8 ± 14.232.4 ± 10.65.632< 0.001
Table 7 Comparison of clinical outcomes between two groups, n (%)/mean ± SD
Item
Control group (n = 49)
Intervention group (n = 49)
Statistic
P value
ICU LOS (days)6.8 ± 2.45.2 ± 1.9t = 3.643< 0.001
MV duration (hours)48.6 ± 18.436.2 ± 14.6t = 3.668< 0.001
28-day mortality 4 (8.2)3 (6.1)χ2 = 0.1540.695
Delirium incidence12 (24.5)4 (8.2)χ2 = 4.6530.031
Respiratory depression 3 (6.1)2 (4.1)χ2 = 0.2110.646
Bradycardia2 (4.1)6 (12.2)χ2 = 1.9650.161


Write to the Help Desk